efavirenz has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alegre, F; Apostolova, N; Blas-Garcia, A; Esplugues, JV; Gibellini, L; Marti-Rodrigo, A; Moragrega, AB; Polo, M | 1 |
| Alvarez, A; Apostolova, N; Blas-Garcia, A; Esplugues, JV; Gomez-Sucerquia, LJ; Moran, A | 1 |
2 other study(ies) available for efavirenz and Liver Neoplasms
| Article | Year |
|---|---|
Lon protease: a novel mitochondrial matrix protein in the interconnection between drug-induced mitochondrial dysfunction and endoplasmic reticulum stress.
Topics: Alkynes; Benzoxazines; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carcinoma, Hepatocellular; Cell Line, Tumor; Cyclopropanes; Endoplasmic Reticulum; Endoplasmic Reticulum Stress; Humans; Liver Neoplasms; Microscopy, Confocal; Mitochondria; Mitochondrial Membranes; Protease La; Rotenone; Thapsigargin | 2017 |
Enhanced oxidative stress and increased mitochondrial mass during efavirenz-induced apoptosis in human hepatic cells.
Topics: Alkynes; Anti-HIV Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Benzoxazines; Carcinoma, Hepatocellular; Cell Cycle; Cell Proliferation; Cell Survival; Chromans; Chromatin Assembly and Disassembly; Cyclopropanes; Dose-Response Relationship, Drug; Female; Glutathione; HeLa Cells; Humans; Liver; Liver Neoplasms; Male; Mitochondria, Liver; Oxidative Stress; Phosphatidylserines; Superoxides; Time Factors | 2010 |